Headquarters: Stamford, Connecticut, United States
Trade prices
Volume:
Market Cap:461.96M
Prev closed:
Open:12.21
High:12.33
Low:12
52 week low:9.63
52 week high:29.65
Dividends:No Dividends
Next ER:August 8, 2022 After Market Closes
Top Stories (CARA)
Company Profile
Cara Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors (KORs).
Talk about Cara Therapeutics below in comments section below.
Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
While many books explain the how of bitcoin, The Internet of Money delves into the why of bitcoin. Acclaimed information-security expert and author of Mastering Bitcoin, Andreas M. Antonopoulos examines and contextualizes the significance of bitcoin through a series of essays spanning the exhilarating maturation of this technology.
